acebutolol and ferrous fumarate

acebutolol has been researched along with ferrous fumarate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Amrein, K; Drexler, C; Lindenau, I; Macher, S; Sareban, N; Schlenke, P1
Aarts, EO; Berends, FJ; Boerboom, A; de Boer, H; de Bruyn Kops, M; de Raaff, C; Janssen, IMC; Schijns, W; van Laarhoven, CJHM; van Wagensveld, B1
Aliu, A; Bertrams Maartens, IA; Bevers, N; Escher, H; Oudshoorn, A; Pierik, MJ; Raijmakers, M; Rezazadeh Ardabili, A; Rosias, P; Stapelbroek, J; Teklenburg, S; van de Feen, C; Van de Vijver, E; van Rheenen, PF; Vande Velde, S; Vreugdenhil, A; Winkens, B1

Trials

2 trial(s) available for acebutolol and ferrous fumarate

ArticleYear
A randomized controlled trial comparing oral and intravenous iron supplementation after Roux-en-Y gastric bypass surgery.
    Clinical nutrition (Edinburgh, Scotland), 2020, Volume: 39, Issue:12

    Topics: Administration, Intravenous; Administration, Oral; Adult; Dietary Supplements; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Gastric Bypass; Humans; Iron Compounds; Iron Deficiencies; Maltose; Postoperative Complications; Treatment Outcome

2020
Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial.
    The Journal of pediatrics, 2023, Volume: 256

    Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Child; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Iron; Maltose; Treatment Outcome

2023

Other Studies

1 other study(ies) available for acebutolol and ferrous fumarate

ArticleYear
High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
    Trials, 2016, 10-28, Volume: 17, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Biomarkers; Blood Donors; Clinical Protocols; Deficiency Diseases; Erythrocyte Count; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Male; Maltose; Middle Aged; Prospective Studies; Research Design; Time Factors; Transferrin; Treatment Outcome; Young Adult

2016